Community/Retail

More than once, I have heard someone suggest that we ought to have a television program that puts a positive spin on pharmacy.

On the heels of what could arguably be the largest data breach identified to date, leading cyber security experts will help attendees of the 2014 NACDS Total Store Expo mitigate cyber attacks.

NACDS Chairman, Rite Aid Chairman and CEO describes collaboration as heart of innovation.

Credits chain, associate members for success of NACDS Total Store Expo: "You are NACDS."

Hospitalization rates for heart disease and stroke have dropped significantly over the past decade.

Study suggests pharmacists are more than qualified to navigate outpatients with HIV through treatment options.

Ceasing treatment may be the only way to determine whether HIV is cured, but doing so carries long-term risks.

Drugs that contain hydrocodone will be moved to a more restrictive category of the Controlled Substances Act.

GERD patients are not following recommendations to avoid acid-triggering foods, according to a recent study.

Game tactics, including rewards and competitions with friends, are making their way into mobile medication adherence apps.

Doctors say experimental Ebola drugs should not be limited to well-off patients.

Aspirin not only prevents the production of pain-causing compounds in the body, but also triggers an enzyme to speed the reduction of inflammation.

Galleon Pharmaceuticals Corp's GAL-021 reverses and prevents respiratory depression associated with opioid use without affecting analgesia.

New indictment alleges FedEx accepted payment from multiple online pharmacies knowing that the money had come from illegal prescription sales.

The Drug Enforcement Administration has officially placed tramadol, a centrally acting opioid analgesic, into schedule IV of the Controlled Substances Act.

You protect your computer with antivirus software. But are you protecting your phone as well?

Learn about the current guideline-recommended treatment options for head lice, including lesser-known guideline-recommended nondrug treatment options.

The FDA has expanded the use of the anticoagulant apixaban (Eliquis) to treat deep vein thrombosis and pulmonary embolism.

Promising treatment protects nonhuman primates from Marburg virus up to 3 days after infection.

The FDA has approved the first needle-free device for injecting the Afluria influenza vaccine in adult patients aged 18 to 64 years.

The FDA has approved the first zinc transporter 8 autoantibody test that may help patients with type 1 diabetes mellitus receive more timely diagnosis and treatment for the disease.

The viral Ice Bucket Challenge and the first effort to estimate the prevalence of amyotrophic lateral sclerosis have raised awareness of the neurodegenerative disease.